14-Day Trial ⭐ Get Full Access to Premium Tools FREE 14-Day Trial ⭐ Get Full Access FREE
$4.68
-0.190 (-3.90%)
At Close: Mar 17, 2025
Forecast Earnings Financials Insider Trading Signals Historical Prices Predictions News Profile

DBV Technologies S.A. Stock Insider Power

Based on the 81 latest insides trades, we have calculated the insider power to be positive at 92.87. In total, the insiders bought 31 440 545 and sold 11 190 DBVT shares in the last 81 trades.

Insider Power

(Last 81 transactions) 		92.87
Buy 31 440 545 Shares
Sell 11 190 Shares

Historical Insider Trades

Date Type Action Person Amount
Jan 30, 2025 Ordinary Shares Sell Mohideen Pharis 600
Dec 04, 2024 Employee Stock Option (right to buy) Buy Tasse Daniel 813 200
Nov 25, 2024 Ordinary Shares Sell Mohideen Pharis 565
Nov 22, 2024 Ordinary Shares Sell Mohideen Pharis 342
Nov 21, 2024 Employee Stock Option (right to buy) Buy Mohideen Pharis 215 000
Nov 21, 2024 Ordinary Shares Buy Mohideen Pharis 35 000
Nov 21, 2024 Ordinary Shares Sell Mohideen Pharis 2 350
Nov 21, 2024 Employee Stock Option (right to buy) Buy Boucinha Virginie 113 000
Nov 21, 2024 Ordinary Shares Buy Boucinha Virginie 19 000
Jul 29, 2024 Ordinary Shares Sell Mohideen Pharis 1 785
May 24, 2024 Ordinary Shares Sell Mohideen Pharis 660
May 22, 2024 Ordinary Shares Sell Mohideen Pharis 382
Mar 08, 2024 Ordinary Shares Buy Tasse Daniel 17 094
Feb 06, 2024 Ordinary Shares Buy Ndu Adora 1 825
Nov 22, 2023 Ordinary Shares Sell Mohideen Pharis 2 245
Nov 20, 2023 Employee Stock Option (right to buy) Buy Boucinha Virginie 113 000
Nov 20, 2023 Ordinary Shares Buy Boucinha Virginie 19 000
Nov 20, 2023 Employee Stock Option (right to buy) Buy Tasse Daniel 806 672
Nov 20, 2023 Employee Stock Option (right to buy) Buy Mohideen Pharis 215 000
Nov 20, 2023 Ordinary Shares Buy Mohideen Pharis 35 000
Nov 06, 2023 Buy Boucinha Virginie 0
Aug 25, 2023 Ordinary Shares Buy Morris Timothy E 12 000
Aug 01, 2023 Ordinary Shares Buy Soland Daniel B 15 000
May 24, 2023 Ordinary Shares Sell Mohideen Pharis 469
Nov 24, 2022 Ordinary Shares Sell Mohideen Pharis 1 792
Click to get the best stock tips daily for free!
ABOUT DBV TECHNOLOGIES S.A.
DBV Technologies S.A.
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults. The milk-induced company is also developing Viaskin Milk that is in Phase I/II clinical t...
Read Full Profile Here
GOLDEN STAR
Ticker Change Signal Date
DESP
$19.20
0.260% Mar 13
AMED
$92.59
0.0540% Mar 13
O
ODD
$44.71
4.18% Mar 13
ALE
$65.32
0.138% Mar 12
HESM
$40.63
6.25% Mar 11
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE